Panbela Therapeutics Inc. (PBLA)
(Delayed Data from OTC)
$0.36 USD
-0.03 (-8.42%)
Updated Jul 25, 2024 10:06 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -2.07 |
EPS Last Quarter | -2.28 |
Last EPS Surprise | -85.37% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -8.38 |
Next Year | -3.75 |
EPS (TTM) | -280.98 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.07 | -2.07 | -8.38 | -3.75 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -2.07 | -2.07 | -8.38 | -3.75 |
High Estimate | -2.07 | -2.07 | -8.38 | -3.75 |
Low Estimate | -2.07 | -2.07 | -8.38 | -3.75 |
Year ago EPS | -159.00 | -53.80 | -316.52 | -8.38 |
Year over Year Growth Est. | 98.70% | 96.15% | 97.35% | 55.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.07 | -2.07 | -8.38 | -3.75 |
7 Days Ago | -2.07 | -2.07 | -8.38 | -3.75 |
30 Days Ago | -2.07 | -2.07 | -8.38 | -3.75 |
60 Days Ago | -2.07 | -2.07 | -8.38 | -3.75 |
90 Days Ago | -1.28 | -1.38 | -5.25 | -3.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.07 | -2.07 | -8.38 | -3.75 |
Zacks Consensus Estimate | -2.07 | -2.07 | -8.38 | -3.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.28 | -65.90 | -53.80 | -159.00 | NA |
Estimate | -1.23 | -24.34 | -41.20 | -94.20 | NA |
Difference | -1.05 | -41.56 | -12.60 | -64.80 | -30.00 |
Surprise | -85.37% | -170.75% | -30.58% | -68.79% | -88.87% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more